Naltrexone for the treatment of alcoholism: A meta-analysis of randomized controlled trials

International Journal of Neuropsychopharmacology

Volumn 8, Issue 2, 2005, Pages 267-280

  Srisurapanont, Manit ^a   Jarusuraisin, Ngamwong ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Alcohol; Alcohol use disorder; Meta analysis; Naltrexone; Opioid antagonists

Indexed keywords

ACAMPROSATE; NALTREXONE; NEFAZODONE; PLACEBO;

ADULT; AGED; ALCOHOLISM; CLINICAL TRIAL; DIZZINESS; DRINKING BEHAVIOR; DRUG EFFICACY; DRUG WITHDRAWAL; FATIGUE; HUMAN; MALE; META ANALYSIS; NAUSEA; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RELAPSE; REVIEW; SHORT COURSE THERAPY; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOLISM; COGNITIVE THERAPY; CONFIDENCE INTERVALS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; PLACEBOS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 20044378930     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145704004997     Document Type: Review

References (56)

1. Ahmadi J, Ahmadi N (2002). A double blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence. German Journal of Psychiatry 5, 85-89.
2. Anton RF, Moak DH, Latham PK, Waid LR, Malcolm RJ, Dias JK, Roberts JS (2001). Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism. Journal of Clinical Psychopharmacology 21, 72-77.
3. Anton RF, Moak DH, Waid LR, Latham PK, Malcolm RJ, Dian JK (1999). Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. American Journal of Psychiatry 156, 1758-1764.
4. Balldin J, Berglund M, Borg S, Mansson M, Bendtsen P, Franck J, Gustafsson L, Halldin J, Nilsson LH, Stolt G, Willander A (2003). A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence. Alcoholism: Clinical and Experimental Research 27, 1142-1149.
5. Berglund M, Thelander S, Salaspuro M, Franck J, Andreasson S, Ojehagen A (2003). Treatment of alcohol abuse: an evidence-based review. Alcoholism: Clinical and Experimental Research 27, 1645-1656.
6. Carmen B, Angeles M, Ana M, Maria AJ (2004). Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction 99, 811-828.
7. Carroll K, Ziedonis D, O'Malley S, McCance-Katz E, Gordon L, Rounsaville B (1993). Pharmacologic interventions for alcohol- and cocaine-abusing individuals: a pilot study of disulfiram vs. naltrexone. American Journal of Addiction 2, 77-79.
8. Chick J, Anton R, Checinski K, Croop R, Drummond DC, Farmer R, Labriola D, Marshall J, Moncrieff J, Morgan MY, Peters T, Ritson B (2000). A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol and Alcoholism 35, 587-593.
9. Cohen J (1992). A power primer. Psychological Bulletin 112, 155-159.
10. Croop RS, Faulkner EB, Labriola DF, for the Naltrexone Usage Study Group (1997). The safety profile of naltrexone in the treatment of alcoholism: results from a multicenter usage study. Archives of General Psychiatry 54, 1130-1135.
11. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Controlled Clinical Trials 7, 177-188.
12. Dorus W, Ostrow DG, Anton R, Cushman P, Collins JF, Schaefer M, Charles HL, Desai P, Hayashida M, Malkerneker U, Willenbring O, Fiscella R, Sather MR (1989). Lithium treatment of depressed and nondepressed alcoholics. Journal of the American Medical Association 262, 1646-1652.
13. Fawcett J, Clark DC, Gibbons RD, Aagesen CA, Pisani VD, Tilkin JM, Sellers D, Stutzman D (1984). Evaluation of lithium therapy for alcoholism. Journal of Clinical Psychiatry 45, 494-499.
14. Galarza NJ, Ramirez DD, Guzman F, Caballero JA, Martinez AJ (1997). The use of natlrexone to treat ambulatory patients with alcohol dependence. Boletin Asociacion Medica de Puerto Rico 89, 157-160.
15. Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT (1999). Pharmacological treatment of alcohol dependence: a review of the evidence. Journal of the American Medical Association 281, 1318-1325.
16. Gastpar M, Bonnet U, Boning J, Mann K, Schmidt LG, Soyka M, Wetterling T, Kielstein V, Labriola D, Croop R (2002). Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study. Journal of Clinical Psychopharmacology 22, 592-598.
17. Guardia J, Caso C, Arias F, Gual A, Sanahuja J, Ramirez M, Mengual I, Gonzalvo B, Segura L, Trujols J, Casas M (2002). A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial. Alcoholism: Clinical and Experimental Research 26, 1381-1387.
18. Hardon DC, Baker D, Hodges JS, Hicks N (1996). Rating the quality of evidence for clinical practice guidelines. Journal of Clinical Epidemiology 49, 749-754.
19. Heinala P, Alho H, Kiianmaa K, Lonnqvist J, Kuoppasalmi K, Sinclair JD (2001). Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind placebo-controlled trial. Journal of Clinical Psychopharmacology 21, 287-292.
20. Hersh D, van Kirk JR, Kranzler HR (1998). Naltrexone treatment of comorbid alcohol and cocaine use disorders. Psychopharmacology (Berlin) 139, 44-52.
21. Herz A (1997). Endogenous opioid systems and alcohol addiction. Psychopharmacology (Berlin) 129, 99-111.
22. Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analysis. British Medical Journal 327, 557-560.
23. Huang X, Peng H, Mai G (2002). Placebo-controlled trial of naltrexone in outpatient treatment of alcohol dependence. Chinese Mental Health Journal 16, 302-303.
24. Jaffe AJ, Rounsaville B, Chang G, Schottenfeld RS, Meyer RE, O'Malley SS (1996). Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching. Journal of Consulting and Clinical Psychology 64, 1044-1153.
25. Johnson BA, Ait Daoud N, Prihoda TJ (2000). Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: from hypotheses to preliminary clinical evidence. Alcoholism: Clinical and Experimental Research 24, 737-742.
26. Kiefer F, Jahn H, Tarnaske T, Helwig H, Briken P, Holzbach R, Kampf P, Stracke R, Baehr M, Naber D, Wiedemann K (2003). Comparing and combing naltrexone and acamprosate in relapse prevention of alcoholism. Archives of General Psychiatry 60, 92-99.
27. Knox PC, Donovan DM (1999). Using naltrexone in inpatient alcoholism treatment. Journal of Psychoactive Drugs 31, 373-388.
28. Kranzler HR, Modesto Lowe V, van Kirk J (2000). Naltrexone vs Nefazodone for treatment of alcohol dependence: a placebo-controlled trial. Neuropsychopharmacology 22, 493-503.
29. Kranzler HR, Van Kirk J (2001). Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcoholism: Clinical and Experimental Research 25, 1335-1341.
30. Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck RA for the Veterans Affairs Naltrexone Cooperative Study 425 Group (2001). Naltrexone in the treatment of alcohol dependence. New England Journal of Medicine 345, 1734-1739.
31. Landabaso MA, Iraurgi I, Sanz J, Calle R, Ruiz de Apodaka J, Jimenez-Lerma JM, Gutierrez-Fraile M (1999). Naltrexone in the treatment of alcoholism: two-year follow up results. European Psychiatry 13, 97-105.
32. Latt NC, Jurd S, Houseman J, Wutzke SE (2002). Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting. Medical Journal of Australia 176, 530-534.
33. Lee A, Tan S, Lim D, Winslow RM, Wong KE, Allen J, Hall W, Parker G (2001). Naltrexone in the treatment of male alcoholics-an effectiveness study in Singapore. Drug and Alcohol Review 20, 193-199.
34. Mason BJ, Ritvo EC, Morgan RO, Salvato FR, Goldberg G, Welch B, Mantero-Atienza E (1994). A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence. Alcoholism: Clinical and Experimental Research 18, 1162-1167.
35. Mason BJ, Salvato FR, Williams LD, Ritvo EC, Cutler RB (1999). A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. Archives of General Psychiatry 56, 719-724.
36. Merry J, Reynolds CM, Bailey J, Coppen A (1976). Prophylactic treatment of alcoholism by lithium carbonate: a controlled study. Lancet 1, 481-482.
37. Modesto-Lowe V, Burleson JA, Hersh D, Bauer LO, Kranzler HR (1997). Effects of naltrexone on cue-elicited craving for alcohol and cocaine. Drug and Alcohol Dependence 49, 9-16.
38. Monti PM, Rohsenow DJ, Swift RM, Gulliver SB, Colby SM, Mueller TI, Brown RA, Gordon A, Abrams DB, Niaura RS, Asher MK (2001). Alcoholism: Clinical and Experimental Research 25, 1634-1647.
39. Morris PLP, Hopwood M, Whelan G, Gardiner J, Drummond E (2001). Naltrexone for alcohol dependence: a randomized controlled trial. Addiction 96, 1565-1573.
40. O'Malley SS, Jaffe AJ, Chang G, Rode S, Schottenfeld R, Meyer RE, Rounsaville B (1996a). Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Archives of General Psychiatry 51, 217-224.
41. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B (1992). Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Archives of General Psychiatry 49, 881-7.
42. O'Malley SS, Jaffe AJ, Rode S, Rounsaville BJ (1996b). Experience of a 'slip' among alcoholics treated with naltrexone and placebo. American Journal of Psychiatry 153, 281-283.
43. O'Malley SS, Rounsaville BJ, Farren C, Namkoong K, Wu R, Robinson J, O'Connor PG (2003). Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care. Archives of Internal Medicine 163, 1695-1704.
44. Oslin D, Liberto JG, O'Brien J, Krois S (1997a). Tolerability of naltrexone in treating older, alcohol-dependence patients. American Journal of Addiction 6, 266-270.
45. Oslin D, Liberto JG, O'Brien J, Krois S, Norbeck J (1997b). Naltrexone as an adjunctive treatment for older patients with alcohol dependence. American Journal of Geriatric Psychiatry 5, 324-332.
46. Overman GP, Teter CJ, Guthrie SK (2003). Acamprosate for the adjunctive treatment of alcohol dependence. Annals of Pharmacotherapy 37, 1090-1099.
47. Peduzzi P, Henderson W, Hartigan P, Lavori P (2002). Analysis of randomized controlled trial. Epidemiological Revieiu 24, 26-38.
48. Rohsenow DJ, Colby SM, Monti PM, Swift RM, Martin RA, Mueller TI, Gordon A, Eaton CA (2000). Predictors of compliance with naltrexone among alcoholics. Alcoholism: Clinical and Experimental Research 24, 1542-1549.
49. Rubio G, Jimenez-Arriero MA, Ponce G, Palomo T (2001). Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment. Alcohol and Alcoholism 36, 419-425.
50. Rubio G, Manzanares J, Lopez-Munoz F, Alamo C, Ponce G, Jimenez-Arriero MA, Palomo T (2002). Naltrexone improves outcome of a controlled drinking program. Journal of Substance Abuse Treatment 23, 361-366.
51. Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995). Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association 273, 408-412.
52. Spanagel R, Zieglgansberger W (1997). Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends in Pharmacological Science 18, 54-59.
53. Streeton C, Whelan G (2001). Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials. Alcohol and Alcoholism 36, 544-552.
54. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP (1992). Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry 49, 876-880.
55. Volpicelli JR, Rhines K, Rhines JS, Volpicelli LA, Alterman AI, O'Brien CP (1997). Naltrexone and alcohol dependence. Archives of General Psychiatry 54, 737-742.
56. Volpicelli JR, Watson NT, King AC, Sherman CE, O'Brien CP (1995). Effect of Naltrexone on alcohol 'high' in alcoholics. American Journal of Psychiatry 152, 613-615.